Press Releases
Date Title and Summary View
Apr 10, 2001 HOLLISTON, Mass., April 10 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported that the United States District Court, District of Massachusetts has denied Harvard University's request for a preliminary injunction prohibiting Harvard Bioscience, Inc. from using the name "Harvard." The Court did issue an order that directs H...
Mar 28, 2001 HOLLISTON, Mass., March 28 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will be a featured speaker at the Thomas Weisel Partners Healthcare Conference 2001 to be held April 2nd and 3rd in San Francisco, California. The theme of the conference will b...
Mar 19, 2001 HOLLISTON, Mass., March 19 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of MitoScan® toxicity screening assays, which offer rapid, convenient alternatives to cellular assays. (Photo: http://www.newscom.com/cgi-bin/prnh/20010319/NEM031) ...
Feb 27, 2001 HOLLISTON, Mass., Feb. 27 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of ScanTox™, a drug safety evaluation tool that provides a more sensitive means of lead optimization than currently available, as well as an in vitro alternative to the much criticized Drai...
Feb 22, 2001 HOLLISTON, Mass., Feb. 22 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the year and the quarter ended December 31, 2000. Revenue for the fourth quarter of 2000 grew 18% before unfavorable foreign exchange effects. Including foreign exchange effects revenue for the fourth quarter ...
Feb 14, 2001 HOLLISTON, Mass., Feb. 14 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) You are invited to listen to our fourth quarter and year ended 2000 conference call. It will be broadcast live over the Internet on Friday, February 23 at 10:00 a.m., EST. Chane Graziano, CEO, David Green, President, and Jim Warren, CFO will conduct the call....
Jan 9, 2001 HOLLISTON, Mass., Jan. 9 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that the underwriters of its initial public offering have exercised in full their overallotment option to purchase an additional 937,500 shares. Including the overallotment, the initial public offering totaled 7,187,500 shares sold by Harvard Bi...
Dec 28, 2000 HOLLISTON, Mass., Dec. 28 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of the high throughput toxicology screening business of Mitoscan Corporation of Madison, Wisconsin. The purchase price for the acquisition consisted of upfront payments of $300,000, additional contingent payments and royalty paym...
Jul 17, 2000 Harvard Apparatus Inc. (HAI) of Holliston, MA, announced today that it has completed the acquisition of substantially all the assets of AmiKa Corp., whose products are at the heart of much of today's gene and protein discovery. Founded in 1996, AmiKa has developed a strong portfolio of patented products and kits for biological preparation and p...
Dec 3, 1999 San Diego, CA and Holliston, MA -- December 3rd, 1999 -- Trega Biosciences, Inc (NASDAQ:TRGA) of San Diego, CA, and Harvard Apparatus, Inc. (HAI) of Holliston, MA, announced today, the acquisition of the Diffusion Chamber Systems product line of Trega’s wholly owned subsidiary, ...
FirstPrevious ...
30
NextLast
= add release to Briefcase